Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95804078 | 9580407 | 8 | F | 20130923 | 20160816 | 20131002 | 20160818 | EXP | GB-ROCHE-1283592 | ROCHE | 78.80 | YR | M | Y | 69.50000 | KG | 20160818 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95804078 | 9580407 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 125085 | 525 | MG | Q3W | ||||||||
| 95804078 | 9580407 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | 125085 | ||||||||||||
| 95804078 | 9580407 | 3 | C | CALCIUM GLUCONATE. | CALCIUM GLUCONATE | 1 | Intravenous (not otherwise specified) | 0 | 1 | G | QID | ||||||||
| 95804078 | 9580407 | 4 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 0 | 2 | DF | BID | ||||||||
| 95804078 | 9580407 | 5 | C | ADCAL (UNITED KINGDOM) | 2 | Oral | 1.5G CALCIUM CARBONATE, 10UG COLECALCIFEROL | 0 | BID | ||||||||||
| 95804078 | 9580407 | 6 | C | LOPERAMIDE | LOPERAMIDE | 1 | Oral | 0 | 4 | MG | QID | ||||||||
| 95804078 | 9580407 | 7 | C | MAGNESIUM GLYCEROPHOSPHATE | MAGNESIUM GLYCEROPHOSPHATE | 1 | Oral | 0 | 97.2 | MG | QID | ||||||||
| 95804078 | 9580407 | 8 | C | OMEPRAZOL | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | QID | ||||||||
| 95804078 | 9580407 | 9 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | FREQUENCY: AS REQUIRED | 0 | 100 | MG | ||||||||
| 95804078 | 9580407 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 1 | G | QD | ||||||||
| 95804078 | 9580407 | 11 | C | DOMPERIDONE | DOMPERIDONE | 1 | Oral | 10-20MG | 0 | ||||||||||
| 95804078 | 9580407 | 12 | C | DOMPERIDONE | DOMPERIDONE | 1 | 0 | ||||||||||||
| 95804078 | 9580407 | 13 | C | THIAMINE. | THIAMINE | 1 | Oral | 0 | 100 | MG | QID | ||||||||
| 95804078 | 9580407 | 14 | C | MAGNAPHATE | 2 | Oral | 0 | 4 | MMOL | QID | |||||||||
| 95804078 | 9580407 | 15 | C | ADCAL D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | Oral | SACHET | 0 | 1 | DF | BID | |||||||
| 95804078 | 9580407 | 16 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 75 | MG | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95804078 | 9580407 | 1 | Colorectal adenocarcinoma |
| 95804078 | 9580407 | 2 | Rectal cancer |
| 95804078 | 9580407 | 3 | Hypocalcaemia |
| 95804078 | 9580407 | 4 | Asthma |
| 95804078 | 9580407 | 5 | Prophylaxis |
| 95804078 | 9580407 | 6 | Diarrhoea |
| 95804078 | 9580407 | 7 | Hypomagnesaemia |
| 95804078 | 9580407 | 8 | Gastrooesophageal reflux disease |
| 95804078 | 9580407 | 9 | Asthma |
| 95804078 | 9580407 | 10 | Pain |
| 95804078 | 9580407 | 11 | Nausea |
| 95804078 | 9580407 | 12 | Vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 95804078 | 9580407 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95804078 | 9580407 | Dyspnoea | |
| 95804078 | 9580407 | Fatigue | |
| 95804078 | 9580407 | Hypocalcaemia | |
| 95804078 | 9580407 | Muscle spasms | |
| 95804078 | 9580407 | Nausea | |
| 95804078 | 9580407 | Sepsis | |
| 95804078 | 9580407 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 95804078 | 9580407 | 1 | 20130905 | 20131107 | 0 | |
| 95804078 | 9580407 | 3 | 20130928 | 0 | ||
| 95804078 | 9580407 | 7 | 20130928 | 0 |